E Fund Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

E Fund Management’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-15,728	Closed	-$292K	–	328
2023 Q3	$292K	Sell	15,728 -6,439	-29%	-$72.8K	0.02%	216
2023 Q2	$245K	Buy	22,167 +7,377	+50%	+$103K	0.02%	249
2023 Q1	$199K	Buy	14,790 +858	+6%	+$14.8K	0.01%	303
2022 Q4	$172K	Sell	13,932 -1,576	-10%	-$22.3K	0.01%	308
2022 Q3	$216K	Sell	15,508 -2,051	-12%	-$33K	0.02%	293
2022 Q2	$242K	Buy	17,559 +6,128	+54%	+$98.1K	0.02%	265
2022 Q1	$186K	Buy	+11,431	New	+$179K	0.01%	301

E Fund Management's ICPT Position: Q4 2023 in Review

E Fund Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 15,728 shares — an estimated $292K sold.

E Fund Management first reported a position in ICPT in Q1 2022 and held it in 7 quarters. The position peaked at $292K in Q3 2023. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

E Fund Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
E Fund Management sold 15,728 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $292K.
E Fund Management first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2022 and held it in 7 quarters.
E Fund Management's Intercept Pharmaceuticals, Inc. position peaked at $292K in Q3 2023.
0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on E Fund Management's 13F filing for Q4 2023, filed 7 Feb 2024.